Zoom conference call scheduled for 9:00 AM ET REHOVOT, Israel , Aug. 12, 2024 /PRNewswire/ -- Evogene Ltd . (Nasdaq: EVGN ) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the second quarter of 2024, on Thursday, August 22, 2024 .
Later that day, Company management, will host a conference call to discuss the results at 9:00 AM Eastern Time ( 4:00 PM Israel time). To join the conference, please register in advance: https://us06web.zoom.
us/webinar/register/WN_K5GBuG1FQ7Srbe_UJ7r2iQ The entire conference will be available online on the company's website a few days after. About Evogene: Evogene Ltd. (Nasdaq: EVGN ) (TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.
Evogene established three unique tech-engines - MicroBoost AI , ChemPass AI and GeneRator AI . Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes ( MicroBoost AI ), small molecules ( ChemPass AI ), and genetic elements ( GeneRator AI ). Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries includi.